Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. M. Cedarbaum
A Phase 2 Randomized Trial of ELND005, Scyllo-Inositol, in Mild to Moderate Alzheimer Disease
Neurology
Neurology
Related publications
Safety and Efficacy Results of a Phase II Randomized, Placebo-Controlled, Dose-Ranging Study of Elnd005 (Scyllo-Inositol) in Mild-To-Moderate Alzheimer's Disease
Alzheimer's and Dementia
Molecular Neuroscience
Gerontology
Health Policy
Developmental Neuroscience
Mental Health
Epidemiology
Geriatrics
Cellular
Psychiatry
Neurology
A Phase II Trial of Huperzine a in Mild to Moderate Alzheimer Disease
Neurology
Neurology
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
Ubiquinol Ameliorates Endothelial Dysfunction in Subjects With Mild-To-Moderate Dyslipidemia: A Randomized Clinical Trial
Nutrients
Nutrition
Food Science
Dietetics
Bapineuzumab for Mild to Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials
BMC Neurology
Medicine
Neurology
Acupuncture for Adolescents With Mild-To-Moderate Myopia: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
MR Spectroscopy for Assessment of Memantine Treatment in Mild to Moderate Alzheimer Dementia
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Journal Club: A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Treat Alzheimer Disease
Neurology
Neurology
